Ishita Drugs & Industries Ltd. reported unaudited earnings results for the third quarter nine months ended December 31, 2011. For the quarter, net sales or income from operations was INR 8.821 million compared to INR 11.664 million a year ago. Profit from operations before other interest and exceptional items were INR 0.274 million compared to INR 0.797 million a year ago. Profit before tax was INR 0.909 million compared to INR 0.714 million a year ago. Net profit was INR 0.609 million or INR 0.20 per basic and diluted share for before and after extraordinary items compared to INR 0.414 million or INR 0.14 per basic and diluted share for before and after extraordinary items a year ago. For the nine months, net sales or income from operations was INR 30.110 million compared to INR 46.548 million a year ago. Profit from operations before other interest and exceptional items were INR 0.935 million compared to INR 3.115 million a year ago. Profit before tax was INR 2.221 million compared to INR 3.225 million a year ago. Net profit was INR 1.668 million or INR 0.56 per basic and diluted share for before and after extraordinary items compared to INR 2.307 million or INR 0.78 per basic and diluted share for before and after extraordinary items a year ago.